Incidental cardiac findings on somatostatin receptor PET/CT: What do they indicate and are they of clinical relevance?

J Nucl Cardiol. 2022 Jun;29(3):1159-1165. doi: 10.1007/s12350-021-02526-9. Epub 2021 Jan 27.

Abstract

We present the case of a 47-year-old man with a history of recurrent episodes of frontal headache, fever, and chest discomfort as well as longstanding, difficult to treat arterial hypertension. Clinical work-up revealed the unexpected finding of an underlying pheochromocytoma as well as recent "silent" myocardial infarction. Our case highlights the importance of paying attention to incidental cardiac findings on somatostatin receptor positron emission tomography/computed tomography, as routinely performed in patients with clinically suspected neuroendocrine tumors. These incidental cardiac findings cannot only indicate a primary or secondary (metastatic) neuroendocrine tumor, but also areas of myocardial inflammation, as somatostatin receptors cannot only be found on the majority of neuroendocrine tumors, but also among other tissues on the surface of activated macrophages and lymphocytes. The detection of myocardial inflammation is of clinical importance and its underlying etiology should be evaluated to prompt eventual necessary treatment, as it is a potential driving force for cardiac remodeling and poor prognosis.

Keywords: 68Ga-DOTATOC; Neuroendocrine tumor; inflammation; myocardial infarction; pheochromocytoma; positron emission tomography; somatostatin receptor.

Publication types

  • Case Reports

MeSH terms

  • Humans
  • Inflammation
  • Male
  • Middle Aged
  • Neuroendocrine Tumors*
  • Octreotide
  • Organometallic Compounds*
  • Positron Emission Tomography Computed Tomography / methods
  • Positron-Emission Tomography / methods
  • Radiopharmaceuticals
  • Receptors, Somatostatin

Substances

  • Organometallic Compounds
  • Radiopharmaceuticals
  • Receptors, Somatostatin
  • Octreotide